Abstract
Purpose
To evaluate the efficacy of Ahmed valve (AV) implantation in patients with uveitic glaucoma.
Methods
In total, 18 patients (19 eyes) with glaucoma secondary to chronic uveitis, who underwent AV implantation were retrospectively reviewed. Visual acuity, intraocular pressure (IOP), and glaucoma medications at the most recent examination prior to surgery, were compared with those of last postoperative examination. The surgical success was defined as IOP less than 21 mmHg and greater than 4 mmHg without loss of light perception and visually devastating complications at the last postoperative examination. Decrease in the number of glaucoma medications was also a criterion for surgical success.
Results
The mean follow-up period was 26±9.7 months. The mean preoperative and postoperative IOPs were 33.3±9.7 (range, 20–57) mmHg and 17.3±10.8 (range, 6–40) mmHg respectively (P<0.0001). The mean number of antiglaucoma medications was 3.5±0.8 (range, 2–5) preoperatively and 1.4±1.3 (range, 0–4) postoperatively (P<0.0001). Valve occlusion (five eyes, 26.3%) was the most commonly observed complication. Surgical success was achieved in 13 eyes (68.4%). The cumulative probability of success was 94.4% at 1 year and 60% at 2 years. Five eyes (26.3%) with IOP greater than 21 mmHg and one (5.3%) with corneal decompensation requiring penetrating keratoplasty were considered as failures.
Conclusions
The implantation of AV is an effective surgical procedure for the management of uveitic glaucoma. The inflammatory background might contribute to the occurrence of valve occlusion, which is the most common complication. Prevention of this complication is an essential factor for improving the surgical outcome.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA . Glaucoma associated with uveitis. Surv Ophthalmol 1997; 41: 361–394.
Jampel HD, Jabs DA, Quigley HA . Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990; 109: 168–173.
Kitazawa Y, Kawase K, Matsushita H, Minobe M . Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991; 109: 1693–1698.
Patitsas CJ, Rockwood EJ, Meisler DM, Lowder CY . Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology 1992; 99: 594–599.
Prata Jr JA, Neves RA, Minckler DS, Mermoud A, Heuer DK . Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 1994; 25: 616–620.
Towler HM, McCluskey P, Shaer B, Lightman S . Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 2000; 107: 1822–1828.
Ceballos EM, Beck AD, Lynn MJ . Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002; 11: 189–196.
Hill RA, Nguyen QH, Baerveldt G, Forster DJ, Minckler DS, Rao N et al. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology 1993; 100: 903–908.
Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-Garcia L . Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 1998; 6: 27–37.
Da Mata AP, Foster CS . Ahmed valve and uveitic glaucoma. Int Ophthalmol Clin 1999; 39: 155–167.
Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS . Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999; 106: 2168–2172.
Ceballos EM, Parrish II RK, Schiffman JC . Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 2002; 109: 2256–2260.
Molteno AC, Sayawat N, Herbison P . Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 2001; 108: 605–613.
Krishna R, Godfrey DG, Budenz DL, Escalona-Camaano E, Gedde SJ, Greenfield DS et al. Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants. Ophthalmology 2001; 108: 621–626.
Kanski JJ, McAllister JA . Trabeculodialysis for inflammatory glaucoma in children and young adults. Ophthalmology 1985; 92: 927–930.
Williams RD, Hoskins HD, Shaffer RN . Trabeculodialysis for inflammatory glaucoma: a review of 25 cases. Ophthalmic Surg 1992; 23: 36–37.
Schlote T, Derse M, Zierhut M . Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol. 2000; 84: 999–1003.
Stavrou P, Murray PI . Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999; 128: 434–439.
Coleman AL, Hill R, Wilson MR, Choplin N, Kotas-Neumann R, Tam M et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 1995; 120: 23–31.
Valimaki J, Airaksinen PJ, Tuulonen A . Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol 1997; 115: 1253–1256.
Taglia DP, Perkins TW, Gangnon R, Heatley GA, Kaufman PL . Comparison of the Ahmed glaucoma valve, the Krupin eye valve with disk, and the double-plate Molteno implant. J Glaucoma 2002; 11: 347–353.
Huang MC, Netland PA, Coleman AL, Siegner SW, Moster MR, Hill RA . Intermediate-term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999; 127: 27–33.
Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Yu F et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999; 128: 198–204.
Melamed S, Cahane M, Gutman I, Blumenthal M . Postoperative complications after Molteno implant surgery. Am J Ophthalmol 1991; 111: 319–322.
Hill RA, Pirouzian A, Liaw L . Pathophysiology of and prophylaxis against late Ahmed glaucoma valve occlusion. Am J Ophthalmol 2000; 129: 608–612.
Englert JA, Freedman SF, Cox TA . The Ahmed valve in refractory pediatric glaucoma. Am J Ophthalmol 1999; 127: 34–42.
Ayyala RS, Zurakowski D, Smith JA, Monshizadeh R, Netland PA, Richards DW et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 1998; 105: 1968–1976.
Acknowledgements
We have not received any public or private support in the preparation of the paper. This paper does not serve the financial or proprietary interests of any individuals or institutions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özdal, P., Vianna, R. & Deschênes, J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye 20, 178–183 (2006). https://doi.org/10.1038/sj.eye.6701841
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701841
Keywords
This article is cited by
-
Long-term surgical outcomes of Ahmed valve implantation in refractory glaucoma according to the type of glaucoma
BMC Ophthalmology (2022)
-
Assessing risk factors for postoperative hypotony in Ahmed glaucoma valve implantation surgery
International Ophthalmology (2021)
-
Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis
International Ophthalmology (2021)
-
Comparison of surgical outcomes of trabeculectomy, Ahmed shunt, and Baerveldt shunt in uveitic glaucoma
Journal of Ophthalmic Inflammation and Infection (2018)
